Loading...
Guest User
Welcome! Please login.
* - Tentative Dates
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
Syschem (India) Limited's revenue decreased by -54.56% and profit after tax (PAT) dropped by -69.23% between the financial year ending with July 31, 2023 and March 31, 2023.
| Period Ended | 31 Jul 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 93.04 | 92.71 | 59.81 | 77.17 |
| Revenue | 59.36 | 130.63 | 65.76 | 74.67 |
| Profit After Tax | 1.39 | 4.51 | -1.71 | -5.57 |
| Net Worth | 23.69 | 22.30 | 6.94 | 7.12 |
| Reserves and Surplus | ||||
| Total Borrowing | 1.52 | 1.61 | 1.75 | 12.56 |
| Amount in ₹ Crore | ||||
Syschem (India) Limited (SIL) is a listed company engaged in bulk drug/intermediate/specialty chemical manufacturing and contract manufacturing. The company is managed by a dedicated group of technical and commercial professionals who have extensive experience in bulk drug manufacturing.
Their comprehensive skills, creative problem-solving approach and proven reliability and compliance make them an ideal business partner. Our strategy is to globalize intellectual property and drive value for shareholders and customers.
We are a fast growing pharmaceutical company manufacturing API/intermediates. Syschem (India) Limited (SIL) is a listed company engaged in manufacturing of bulk pharmaceutical products/intermediates/specialty chemicals and contract manufacturing. The company is managed by a group of dedicated technical and commercial professionals who have extensive experience in the manufacturing of bulk pharmaceutical products.
